These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Barth RJ. Breast Cancer Res Treat; 1999 Oct; 57(3):291-5. PubMed ID: 10617306 [Abstract] [Full Text] [Related]
5. A retrospective review of phyllodes tumours of the breast: A single institution experience. Ganesh V, Drost L, Lee J, Wan BA, Zhang L, Rakovitch E, Vesprini D, Slodkowska E, Zeng KL, Sousa P, Yee C, Lam H, Chow E. Breast; 2018 Apr; 38():52-57. PubMed ID: 29232600 [Abstract] [Full Text] [Related]
9. Management of phyllodes breast tumors. Guillot E, Couturaud B, Reyal F, Curnier A, Ravinet J, Laé M, Bollet M, Pierga JY, Salmon R, Fitoussi A, Breast Cancer Study Group of the Institut Curie. Breast J; 2011 Apr; 17(2):129-37. PubMed ID: 21251125 [Abstract] [Full Text] [Related]
12. Massive infarction of a recurrent phyllodes tumor of the breast: MRI-findings. Verslegers I, Tjalma W, Van Goethem M, Colpaert C, Biltjes I, De Schepper AM, Parizel PM. JBR-BTR; 2004 Apr; 87(1):21-2. PubMed ID: 15055329 [Abstract] [Full Text] [Related]
16. Phyllodes tumours of the breast: retrospective analysis of a University Hospital's experience. Toh YF, Cheah PL, Looi LM, Teoh KH, Tan PH. Malays J Pathol; 2016 Apr; 38(1):19-24. PubMed ID: 27126660 [Abstract] [Full Text] [Related]
17. Recurrent malignant phyllodes tumor of the breast: A case report. Wang Q, Su J, Lei Y. Medicine (Baltimore); 2017 Dec; 96(49):e9069. PubMed ID: 29245318 [Abstract] [Full Text] [Related]